ectopic ACTH secretion syndrome
ectopic ACTH secretion syndrome
Explore linked clinical trials. Standard reference: MONDO:004347214 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome | ACTH-dependent Cushing syndrome, Cushing syndrome, Neoplasms by Histologic Type, Neoplasms by Site, Nutritional and Metabolic Diseases, Paraneoplastic Endocrine Syndromes, adenocarcinoma, adrenal cortex disorder, adrenal cortex neoplasm, adrenal gland cancer, adrenal gland disorder, adrenal gland hyperfunction, brain disorder, carcinoma, cardiovascular disorder, central nervous system disorder, diabetes mellitus, ectopic ACTH secretion syndrome, endocrine system disorder, epithelial neoplasm, glucose metabolism disease, hyperpituitarism, hypertensive disorder, hypothalamic disorder, malignant endocrine neoplasm, metabolic disease, neoplasm, nervous system disorder, paraneoplastic syndrome, pituitary gland disorder, type 2 diabetes mellitus, vascular disorder | Active, not recruiting | Phase 2 | 2026-10-09 | NCT03604198 | |
| Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks | Bone Diseases, Metabolic, Neoplasms by Site, Nutritional and Metabolic Diseases, Paraneoplastic Endocrine Syndromes, adrenal gland cancer, adrenal gland disorder, adrenal gland hyperfunction, bone disorder, cardiovascular disorder, ectopic ACTH secretion syndrome, endocrine system disorder, glucose metabolism disease, hyperaldosteronism, hyperinsulinism, hypertensive disorder, malignant endocrine neoplasm, metabolic disease, musculoskeletal system disorder, neoplasm, paraneoplastic syndrome, vascular disorder | Recruiting | Not stated | 2026-10-08 | NCT03374215 | |
| Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) | Cushing syndrome, Nutritional and Metabolic Diseases, Paraneoplastic Endocrine Syndromes, adrenal gland disorder, adrenal gland hyperfunction, diabetes mellitus, ectopic ACTH secretion syndrome, endocrine system disorder, glucose metabolism disease, metabolic disease, neoplasm, paraneoplastic syndrome, type 2 diabetes mellitus | Recruiting | Phase 2 | 2026-10-06 | NCT07296484 | |
| Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cushing syndrome, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Paraneoplastic Endocrine Syndromes, Urogenital Abnormalities, Urogenital Diseases, adrenal gland disorder, adrenal gland hyperfunction, adrenogenital syndrome, congenital adrenal hyperplasia, disorder of sexual differentiation, ectopic ACTH secretion syndrome, endocrine system disorder, gonadal disorder, hereditary disease, inborn errors of metabolism, metabolic disease, neoplasm, paraneoplastic syndrome, steroid inherited metabolic disorder | Recruiting | Phase 2 | 2026-09-25 | NCT07138274 | |
| Metyrapone for Mild Autonomous Cortisol Secretion (MACS) | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cushing syndrome, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Paraneoplastic Endocrine Syndromes, Urogenital Abnormalities, Urogenital Diseases, adrenal gland disorder, adrenal gland hyperfunction, adrenogenital syndrome, congenital adrenal hyperplasia, disorder of sexual differentiation, ectopic ACTH secretion syndrome, endocrine system disorder, gonadal disorder, hereditary disease, inborn errors of metabolism, metabolic disease, neoplasm, paraneoplastic syndrome, steroid inherited metabolic disorder | Active, not recruiting | Phase 2 | 2026-09-25 | NCT06106295 | |
| A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome | ACTH-dependent Cushing syndrome, Cushing syndrome, Paraneoplastic Endocrine Syndromes, adrenal gland disorder, adrenal gland hyperfunction, brain disorder, central nervous system disorder, ectopic ACTH secretion syndrome, endocrine system disorder, hyperpituitarism, hypothalamic disorder, neoplasm, nervous system disorder, paraneoplastic syndrome, pituitary gland disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-08-19 | NCT05804669 | |
| EndoSense: Continuous Real-Time Monitoring of Health Markers in Endocrine and Metabolic Disorders | Body Weight, Cushing syndrome, Nutritional and Metabolic Diseases, Overweight, Paraneoplastic Endocrine Syndromes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, adrenal gland disorder, adrenal gland hyperfunction, cardiovascular disorder, ectopic ACTH secretion syndrome, endocrine system disorder, hyperaldosteronism, hypertensive disorder, neoplasm, nutritional disorder, obesity disorder, overnutrition, paraneoplastic syndrome, primary aldosteronism, vascular disorder | Active, not recruiting | Not applicable | 2026-07-27 | NCT07727356 | |
| IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion | Adrenal incidentaloma, Body Weight, Body Weight Changes, Cushing syndrome, Insulin Resistance, Nutritional and Metabolic Diseases, Paraneoplastic Endocrine Syndromes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, adrenal gland disorder, adrenal gland hyperfunction, ectopic ACTH secretion syndrome, endocrine system disorder, glucose metabolism disease, hyperinsulinism, metabolic disease, neoplasm, paraneoplastic syndrome | Recruiting | Not applicable | 2026-03-27 | NCT07361874 | |
| Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS) | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Paraneoplastic Endocrine Syndromes, Urogenital Abnormalities, Urogenital Diseases, adrenal gland disorder, adrenogenital syndrome, cardiovascular disorder, congenital adrenal hyperplasia, disorder of sexual differentiation, ectopic ACTH secretion syndrome, endocrine system disorder, gonadal disorder, hereditary disease, hypertensive disorder, inborn errors of metabolism, metabolic disease, neoplasm, paraneoplastic syndrome, steroid inherited metabolic disorder, vascular disorder | Recruiting | Phase 4 | 2026-03-05 | NCT07247058 | |
| Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS) | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cushing syndrome, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Paraneoplastic Endocrine Syndromes, Urogenital Abnormalities, Urogenital Diseases, adrenal gland disorder, adrenal gland hyperfunction, adrenogenital syndrome, congenital adrenal hyperplasia, disorder of sexual differentiation, ectopic ACTH secretion syndrome, endocrine system disorder, gonadal disorder, hereditary disease, inborn errors of metabolism, metabolic disease, neoplasm, paraneoplastic syndrome, steroid inherited metabolic disorder | Recruiting | Phase 2 | 2026-02-11 | NCT07104812 | |
| Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome | Cushing syndrome, Paraneoplastic Endocrine Syndromes, adrenal gland disorder, adrenal gland hyperfunction, cardiovascular disorder, ectopic ACTH secretion syndrome, endocrine system disorder, hypertensive disorder, neoplasm, paraneoplastic syndrome, vascular disorder | Not yet recruiting | Phase 4 | 2025-12-10 | NCT07247162 | |
| Cerebrovascular Disease: Quality of Life (CODE: QoL) | Cushing syndrome, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemorrhage, Intracranial Hemorrhages, Lower Urinary Tract Symptoms, Male Urogenital Diseases, Paraneoplastic Endocrine Syndromes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Stroke, Acute, Urinary Incontinence, Urination Disorders, Urogenital Diseases, Urological Manifestations, brain disorder, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ectopic ACTH secretion syndrome, intracerebral hemorrhage, neoplasm, nervous system disorder, paraneoplastic syndrome, stroke disorder, transient ischemic attack, urinary system disorder, vascular disorder | Recruiting | Not stated | 2024-06-05 | NCT06443268 | |
| Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden Death | ACTH-independent Cushing syndrome, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Paraneoplastic Endocrine Syndromes, adrenal gland disorder, adrenal gland hyperfunction, ectopic ACTH secretion syndrome, endocrine system disorder, hyperaldosteronism, malignant endocrine neoplasm, neoplasm, neuroendocrine neoplasm, paraganglioma, paraneoplastic syndrome, pheochromocytoma, primary aldosteronism, primitive neuroectodermal tumor | Active, not recruiting | Not stated | 2024-04-16 | NCT05446779 | |
| A Prospective Cohort Study for Patients With Adrenal Diseases | Adrenal incidentaloma, Cushing syndrome, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Paraneoplastic Endocrine Syndromes, adenocarcinoma, adrenal cortex adenoma, adrenal cortex disorder, adrenal cortex neoplasm, adrenal gland cancer, adrenal gland disorder, adrenal gland hyperfunction, carcinoma, ectopic ACTH secretion syndrome, endocrine system disorder, epithelial neoplasm, hyperaldosteronism, malignant endocrine neoplasm, neoplasm, neuroendocrine neoplasm, paraganglioma, paraneoplastic syndrome, pheochromocytoma, primary aldosteronism, primitive neuroectodermal tumor | Enrolling by invitation | Not stated | 2020-03-18 | NCT03474237 |